AstraZeneca PLC vs SAP
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
AstraZeneca PLC
$266.0B
์์ #52
SAP
$274.9B
์์ #49
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- SAP์ด(๊ฐ) 1997๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2000๋ ๊น์ง SAP์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- SAP์ด(๊ฐ) 2003๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2008๋ ๊น์ง SAP์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- SAP์ด(๊ฐ) 2009๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2014๋ ๊น์ง SAP์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- SAP์ด(๊ฐ) 2015๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2021๋ ๊น์ง SAP์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- SAP์ด(๊ฐ) 2024๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- AstraZeneca PLC์ด(๊ฐ) 2025๋ ๊น์ง SAP์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- SAP์ด(๊ฐ) 2026๋ ๊น์ง AstraZeneca PLC์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | AstraZeneca PLC | SAP | ์ ๋ |
|---|---|---|---|
| 2026 | $266.0B | $274.9B | SAP |
| 2025 | $282.2B | $278.8B | AstraZeneca PLC |
| 2024 | $196.9B | $280.0B | SAP |
| 2023 | $198.1B | $173.6B | AstraZeneca PLC |
| 2022 | $195.3B | $114.0B | AstraZeneca PLC |
| 2021 | $163.9B | $150.4B | AstraZeneca PLC |
| 2020 | $136.9B | $137.7B | SAP |
| 2019 | $132.8B | $139.5B | SAP |
| 2018 | $97.9B | $102.2B | SAP |
| 2017 | $85.9B | $113.7B | SAP |
| 2016 | $64.5B | $86.3B | SAP |
| 2015 | $76.6B | $77.7B | SAP |
| 2014 | $76.2B | $67.3B | AstraZeneca PLC |
| 2013 | $61.7B | $82.7B | SAP |
| 2012 | $46.3B | $75.2B | SAP |
| 2011 | $42.7B | $48.3B | SAP |
| 2010 | $40.3B | $45.5B | SAP |
| 2009 | $38.9B | $41.5B | SAP |
| 2008 | $32.3B | $31.5B | AstraZeneca PLC |
| 2007 | $32.3B | $43.8B | SAP |
| 2006 | $39.1B | $45.0B | SAP |
| 2005 | $34.5B | $37.9B | SAP |
| 2004 | $25.2B | $36.9B | SAP |
| 2003 | $32.9B | $34.4B | SAP |
| 2002 | $23.4B | $16.1B | AstraZeneca PLC |
| 2001 | $30.5B | $26.2B | AstraZeneca PLC |
| 2000 | $33.1B | $27.6B | AstraZeneca PLC |
| 1999 | $25.7B | $42.5B | SAP |
| 1998 | $27.2B | $29.3B | SAP |
| 1997 | $21.4B | $21.6B | SAP |
| 1996 | $16.3B | $9.4B | AstraZeneca PLC |
| 1995 | $11.1B | $10.4B | AstraZeneca PLC |